Dr Joanna Macdonald

Steering Straight: Adapting suicide risk safety planning as a prevention‐focused self‐management resource for the Australian farming community

Sonya Duke, Joanna Macdonald, Alison Kennedy

(2023), Vol. 31, pp. 471-483, Australian Journal of Rural Health, London, Eng., C1

Co-designing a peer-led model of delivering behavioural activation for people living with depression or low mood in Australian farming communities

A Kennedy, K Gunn, S Duke, M Jones, E Brown, K Barnes, J Macdonald, S Brumby, V Versace, R Gray

(2023), Vol. 31, pp. 556-568, Australian Journal of Rural Health, London, Eng., C1

Participant perspectives of an online co-design process to develop a prevention-focused mental health and well-being platform for primary producers

M Binder, H Beks, V Versace, J Macdonald, C Mckay, S Cunningham, G Wall, K Barnes, S Cornell, M Cock, A Kennedy, K Namara

(2022), Vol. 30, pp. 719-729, Australian Journal of Rural Health, C1

From co-design to co-production: Approaches, enablers, and constraints in developing a public health, capacity-building solution

C Cosgrave, A Kennedy, T Dietrich, K Gunn, J MacDonald, C McKay, S Cunningham, S Haren, J Lewis

(2022), Vol. 30, pp. 738-746, Australian Journal of Rural Health, Australia, C1

Translating co-design from face-to-face to online: An australian primary producer project conducted during covid-19

A Kennedy, C Cosgrave, J Macdonald, K Gunn, T Dietrich, S Brumby

(2021), Vol. 18, International Journal of Environmental Research and Public Health, Switzerland, C1

Bifunctional aptamer-doxorubicin conjugate crosses the blood-brain barrier and selectively delivers Its payload to EpCAM-positive tumor cells

J Macdonald, D Denoyer, J Henri, A Jamieson, I Burvenich, N Pouliot, S Shigdar

(2020), Vol. 30, pp. 117-128, Nucleic acid therapeutics, New Rochelle, N.Y., C1

Radiolabelled aptamers for theranostic treatment of cancer

Umair Khalid, Chris Vi, Justin Henri, Joanna Macdonald, Peter Eu, Giovanni Mandarano, Sarah Shigdar

(2019), Vol. 12, Pharmaceuticals, Basel, Switzerland, C1

Aptamers as potential therapeutic agents for ovarian cancer

J Henri, J Macdonald, M Strom, W Duan, S Shigdar

(2018), Vol. 145, pp. 34-44, Biochimie, Amsterdam, The Netherlands, C1

EpCAM immunotherapy versus specific targeted delivery of drugs

J Macdonald, J Henri, K Roy, E Hays, M Bauer, R Veedu, N Pouliot, S Shigdar

(2018), Vol. 10, Cancers, Switzerland, C1

Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases

J Macdonald, J Henri, L Goodman, D Xiang, W Duan, S Shigdar

(2017), Vol. 8, pp. 777-784, ACS Chemical Neuroscience, United States, C1

The Application of Aptamers for Immunohistochemistry

M Bauer, J Macdonald, J Henri, W Duan, S Shigdar

(2016), Vol. 26, pp. 120-126, Nucleic Acid Therapeutics, United States, C1

Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity

J MacDonald, P Houghton, D Xiang, W Duan, S Shigdar

(2016), Vol. 26, pp. 348-354, Nucleic Acid Therapeutics, United States, C1

Cancer stem cells: a contentious hypothesis now moving forward

M O'Connor, D Xiang, S Shigdar, J Macdonald, Y Li, T Wang, C Pu, Z Wang, L Qiao, W Duan

(2014), Vol. 344, pp. 180-187, Cancer letters, Shannon, Ireland, C1

Aptamers as theranostic agents: modifications, serum stability and functionalisation

S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al.Shamaileh, L Qiao, M Wei, S Zhou, Y Zhu, L Kong, S Bhattacharya, C Li, W Duan

(2013), Vol. 13, pp. 13624-13637, Sensors, Basel, Switzerland, C1